CALL/ABBOTT LABORATORIES/120/0.1/20.09.24 Stock

Warrant

DE000GG0YGY2

Real-time BOERSE MUENCHEN 08:25:07 2024-07-17 am EDT
0.028 EUR -12.50% Intraday chart for CALL/ABBOTT LABORATORIES/120/0.1/20.09.24
Current month-30.43%
1 month-28.89%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-17 0.028 -12.50%
24-07-16 0.032 -20.00%
24-07-15 0.04 -9.09%
24-07-12 0.044 -6.38%
24-07-11 0.047 +46.88%

Real-time BOERSE MUENCHEN

Last update July 17, 2024 at 08:25 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GG0YGY
ISINDE000GG0YGY2
Date issued 2023-12-11
Strike 120 $
Maturity 2024-09-20 (65 Days)
Parity 10 : 1
Emission price 0.26
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.849
Lowest since issue 0.028
Spread 0.019
Spread %38.78%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
102.7 USD
Average target price
124.8 USD
Spread / Average Target
+21.48%
Consensus